|
Editor's note: We're sorry we're late! Technical difficulties delayed the send of some of our newsletters today. We appreciate your readership.
Today's Rundown
Featured Story | | | Thursday, March 12, 2020 Daniel Menichella started the month as CureVac CEO, one of the privileged few to discuss the coronavirus response with the U.S. president and kick-starting a vaccine trial against COVID-19. |
|
|---|
|
|  |
AlivaMab® Mouse: Establishing the Fastest and Most De-Risked Path from Antibody Drug Discovery to Market. AlivaMab Mouse from Ablexis is a trusted and demonstrably better platform for the successful and efficient discovery of therapeutic-quality antibodies. It is uniquely differentiated to deliver quality, speed and value for antibody drug discovery projects, even the most challenging. Contact us at [email protected] to learn more. ablexis.com |
Top Stories Thursday, March 12, 2020 Just before Christmas and, critically, after announcing some positive data, Forty Seven sat down at Gilead Sciences' HQ with its C-suite to talk M&A. Thursday, March 12, 2020 Harbour BioMed has raised $75 million to continue moving multiple candidates through the clinic. The round, which Harbour described as a “series B+,” comes shortly after the antibody specialist took its first internally originated candidate into the clinic outside of greater China. Thursday, March 12, 2020 Back in December, PDL Biopharma decided to call it quits. The onetime antibody developer weighed options to “unlock the value of its portfolio,” and now, has arrived at a plan to completely liquidate the company and dissolve it by the end of the year. PDL’s board approved the plan in February. Thursday, March 12, 2020 Kymera Therapeutics is plotting a big transition in 2020. After spending four years building the company around its protein degradation technology, it’s setting its sights on the clinic—and it’s just bagged $102 million to do so. The new capital will move up to three programs into the clinic in 2021. Thursday, March 12, 2020 Aldeyra Therapeutics has halted clinical development of two systemic disease programs to stretch out its cash runway to the end of next year. The action is intended to enable Aldeyra keep pushing its ocular disease programs through late-phase development despite its falling cash reserves. Wednesday, March 11, 2020 Bayer and the Massachusetts Biotechnology Council are this week opening a regulatory best practice center for start-up biotech and digital health companies. Their goal? Get new drug developers to start thinking about regulatory requirements earlier. Thursday, March 12, 2020 Triple-negative breast cancer is hard to treat, because it lacks common markers for drugs to target. Now, instead of going after the tumors directly, a research team led by the University of Sussex has found a target in their surrounding environment and identified Gilead's FDA-approved blood cancer med Zydelig as a possible treatment. Wednesday, March 11, 2020 The FDA approved Roche’s diagnostic for triaging women whose primary cervical cancer screenings have tested positive for the human papillomavirus (HPV). The company’s CINtec PLUS Cytology test is designed to identify women with HPV infections who are most likely to develop cervical pre-cancers. |  |
Experts in our field; with 20+ years’ experience in Viral Vector & plasmid DNA (R&D, High Quality and GMP) manufacture for pre-clinical, clinical & commercial supply. Take a virtual tour of our facilities & find out more about our expansion project. |
Enrollment Showcase | | | Presented by: Global EMBA for Healthcare & the Life Sciences, University of Toronto
Prepare to step up in your career, build the expertise you need to reshape your organization, and explore opportunities worldwide. |
|
|---|
|
Resources Sponsored by: Catalent
Learn how to drive excellence within the forecasting process and utilize forecasting throughout the clinical study to better plan clinical supply budgets and project timelines. Explore how to identify potential supply-related issues before they can negatively impact your study. Sponsored by: Catalent
Whether a study is simple or highly complex, forecasting and simulation reports serve as data driven communication tools to help minimize risks and keep the study on track. Learn more about forecasting solutions for informed decision making and supporting contingency planning for clinical study. Sponsored by: Catalent
Learn about a real-world example of how clinical supply management expertise was applied to overcome inventory challenges for a complex, global study. Sponsored by: Outer Edge Technology
See why innovative BioPharma’s are partnering with Cloud Service Provider’s to design, manage and implement cloud strategies to smooth the path to FDA approval and enhance their competitive prowess. Sponsored by: Metabolon
Metabolomics can help you streamline your drug development process by providing the framework to make a stronger, more confident, and more valuable case for a molecule in a shorter timeframe. Sponsored by: Epsilon
Download this e-book to learn 9 ways to enhance the customer experience within healthcare marketing. Sponsored by: Reprints Desk/Research Solutions
3 ways you may be overspending on scientific literature access, and how to fix them. Sponsored by: Baxter
When different drug products are produced in shared facilities, potential for cross-contamination needs to be addressed. Outsourcing to a CMO with experience in multiproduct facilities can be an option. Sponsored by: WCG Metrics Champion Consortium
Ineffective measurement could mean wasting both time and money. This whitepaper showcases a custom-built Metric Maturity Model that helps illustrate and define the process for measuring the right things the right way. Sponsored by: Eagle Productivity Solutions
Mediocre adoption rates aren’t due to poorly designed software or lazy users. They’re the result of how skills are trained. Achieve high adoption rates by implementing the right methodology with a focus on behavior change. Sponsored by: The Kinetix Group
Read about the innovative ways payers are making smart moves in the healthcare game. Sponsored by: H1
Biopharma companies don't want to go to market with a product no one knows about. H1 has homed in on the often time-consuming research and engagement phases that companies must ace for a successful launch, said Ariel Katz, co-founder of H1. Sponsored by: Clinical Ink
Download this free white paper to learn how a BYOD ePRO approach is beneficial to your trial. Sponsored by: Catalent
This whitepaper discusses the benefits of end-to-end solutions and share case studies on how flexible manufacturing strategies can accommodate the changing landscape of pharmaceutical products and help bring a drug to market. Sponsored by: Accenture
Kevin Julian, senior managing director of Accenture’s life sciences practice, recently sat down with FierceBiotech to discuss market trends and Accenture’s new technology platform, INTIENT. Sponsored by: Blue Matter Consulting
White paper describing how a biopharma company can successfully differentiate an oncology product when the clinical profile alone is not enough to get the job done.
Bioprocessing Summit Europe – Practical Solutions for Today’s Bioprocess Challenges March 24-26 2020 | Barcelona, Spain BioBasics 101: The Biology of Biotech March 26-27, 2020 | Boston, MA Clinical Trial Innovation Summit – Technology, Data, Operations, Oversight April 6-8, 2020 | Cambridge, MA Drug Discovery Chemistry – Choose from 45 Presentations from Top Pharma April 13-17, 2020 | San Diego, CA Medical Affairs Strategic Summit (MASS) East April 14-16, 2020 | New Brunswick, NJ BioBasics 101: The Biology of Biotech April 16-17, 2020 | Philadelphia, PA Drug Development Immersion April 23-24, 2020 | Boston, MA 2nd Annual World Pharma Week: Driving Innovation in Drug R&D June 2-4, 2020 | Boston, MA European Healthcare Compliance Certificate Program June 2-5, 2020 | Paris, France BIO International Convention June 8-11, 2020 | San Diego, CA U.S. Healthcare Compliance Certificate Program June 8-10, 2020 | Newark, NJ Drug Development Boot Camp® 2020 November 18-19, 2020 | Register now and begin Pre-Boot Camp Preparation. | Take your new medicine development skills to the next level. | 
